Page last updated: 2024-11-01

nifedipine and Basal Ganglia Diseases

nifedipine has been researched along with Basal Ganglia Diseases in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research Excerpts

ExcerptRelevanceReference
" Fifty-one patients diagnosed with paranoid schizophrenia received haloperidol in combination with nifedipine (25 patients) or haloperidol only (26 patients) during 26 weeks."5.13[The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics]. ( Popov, MIu, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Popov, MIu1
Singh, I1

Trials

1 trial available for nifedipine and Basal Ganglia Diseases

ArticleYear
[The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:6

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Female; Haloperidol; Humans; Male; Nifedipine;

2008

Other Studies

1 other study available for nifedipine and Basal Ganglia Diseases

ArticleYear
Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 150

    Topics: Adult; Basal Ganglia Diseases; Clopenthixol; Humans; Male; Nifedipine

1987